Triazine-Based Acylating Agents for Sphingolipid Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing sphingolipids, such as ceramides and glycosphingolipids, are inefficient and costly, relying on extraction from animal sources which is laborious and yields low purity compounds with potential biological contaminants.
Innovation Solution
A novel method involving the N-acylation of lysosphingolipids using 1,3,5-triazine-based acylating agents, which allows for the production of sphingolipids in high purity and yield, without the need for water-free solvents or exclusion of air, and using synthetic and/or biotechnological approaches for lysosphingolipid sourcing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If extraction from animal sources is used, then sphingolipids can be obtained, but the process is laborious and yields low purity compounds with potential biological contaminants
Solution Approach 1:
The patent extracts and isolates sphingolipids from complex biological mixtures using chromatographic methods, separating the target compounds from impurities and contaminants present in animal tissue extracts, thereby achieving high purity without requiring large-scale extraction operations
Solution Approach 2:
The patent synthesizes sphingolipids through chemical reactions starting from simpler precursors, creating molecular copies of the target compounds in a controlled laboratory setting rather than extracting them from complex biological sources, thus eliminating contamination issues
2Manufacturing precision
If standard amide bond coupling reagents are used for N-acylation, then sphingolipids can be produced, but expensive and unstable coupling reagents require water-free solvents and air exclusion
Solution Approach 1:
The patent changes the chemical parameters of the acylating agents, using activated esters and acid chlorides instead of standard coupling reagents, which allows the reaction to proceed in conventional solvents without requiring water-free conditions or air exclusion, thereby simplifying the manufacturing process
Solution Approach 2:
The patent employs readily available, stable acylating agents such as activated esters and acid chlorides that can be used in conventional laboratory conditions without requiring expensive specialized reagents or stringent process controls, making the synthesis more economical and easier to manufacture
3Productivity
If lipases are used for N-acylation, then enzymatic catalysis is achieved, but the enzymes are not specific for the amino group and act on hydroxyl groups too, leading to mixtures requiring lengthy purification
Solution Approach 1:
The patent uses acylating agents with specific reactivity characteristics that target the amino group selectively, creating local chemical reactivity differences that allow the amino group to react preferentially over hydroxyl groups, thereby producing pure N-acylated products without requiring extensive purification
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides an efficient and economic route to producing a diverse set of biologically relevant sphingolipids, offering high purity and yield, and overcoming the limitations of traditional extraction methods.
Implementation Method 1
reacting a lysosphingolipid of formula (2) with one or more triazine-based acylating agents of formula (3), thereby producing the sphingolipid of formula (1)
Data Source
AI summary
The present invention relates to a novel and efficient method for the production of sphingolipids via the N-acylation of lysosphingolipids. The method comprises the use of 1,3,5-triazine-based acylating agents, and is especially suitable for the production of ceramides and glycosphingolipids. The present invention further relates to novel 1,3,5-triazine-based acylating agents.